Miracle Messages Evaluation

November 12, 2023 updated by: Benjamin F. Henwood, University of Southern California

Miracle Friends and Miracle Money Evaluation

The project will conduct a randomized control trial (RCT) of an innovative program for people experiencing homelessness (PEH) that initially designed to address social isolation and loneliness among people experiencing homelessness but subsequently paired with an economic poverty-reduction intervention. The social support intervention, known as "Miracle Friends," pairs an unhoused person with a volunteer "phone buddy." The poverty reduction intervention, known as "Miracle Money," provides guaranteed basic income of $750 per month for 1 year to Miracle Friends participants.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The project will conduct a randomized control trial (RCT) of an innovative program for people experiencing homelessness (PEH) that initially designed to address social isolation and loneliness among people experiencing homelessness but subsequently paired with an economic poverty-reduction intervention. The social support intervention, known as "Miracle Friends (MF)," pairs an unhoused person with a volunteer "phone buddy." The poverty reduction intervention, known as "Miracle Money (M$)," provides guaranteed basic income of $750 per month for 1 year to MF participants. The RCT will have 3 arms of PEH who expressed interest in the phone buddy program: (1) those assigned to Miracle Friends; (2) those assigned to Miracle Money, which is not disclosed until after they actively engage in the Miracle Friends program; (3) And those assigned to a waitlist for Miracle Friends. To recruit for the study, the Miracle Friends program engage PEH through a variety of homeless services partners and introduce the MF program. Anyone who is interested in the MF program is provided information about a 15-month longitudinal study and referred to the research team to complete an eligibility screener. The research team explains the interview protocols that include receiving a $30 incentive each time a survey is completed that includes a baseline and 5 quarterly surveys. Participants will also be notified about being randomly selected to either be offered MF or put on a waitlist. Those assigned to the M$ are not notified about receiving monthly income until after they engage in the MF program. Information about frequency of contact with the MF social support volunteer and volunteer demographics will be provided directly from the Miracle Friends administrative data records.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
759

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • California
      • Los Angeles, California, United States, 90039
        • Miracle Messages

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • being 18 years old or older;
  • speaks English;
  • currently experiencing homelessness;
  • has expressed interest in signing up for the Miracle Friends ("phone buddy") program.

Exclusion Criteria:

  • not meeting the inclusion criteria;
  • not able to provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Miracle Friends
Participants selected to receive a social support "phone buddy" program.
Other: Social Support
Social support "phone buddy" program.
Other Names:
  • Miracle Friends
No Intervention: waitlist
Waitlisted for the social support "phone buddy" program.
Experimental: Miracle Money
Participants who receive $750 monthly income for 12 months based on having engaged in the Miracle Friends program
Other: Social Support
Social support "phone buddy" program.
Other Names:
  • Miracle Friends
Other: Basic income
$750 per month for 12 months
Other Names:
  • Miracle Money

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Homelessness/Housing status using questions from the Los Angeles Homeless Count
Time Frame: Measured quarterly for 15 months.
In the past 30 days, please indicate all places where you have slept for at least one night: 1. My own apartment or home 2. Someone else's apartment or home 3. In a shelter, emergency, temporary housing, 4. Hotel/motel provided by an agency 5. Outside on the street, park, or beach 6. Tent or makeshift shelter 7. In a bus station, train station, airport 8. Abandoned building 9. In a vehicle (car, van, recreation vehicle (RV), truck) 10. An institution, hospital, or facility
Measured quarterly for 15 months.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Employment status using questions from the Los Angeles Homeless Count
Time Frame: Measured quarterly for 15 months.

What is your employment status?

  1. Employed, full-time (35 hours a week or more)
  2. Employed, part-time
  3. Unemployed, looking for work
  4. Unemployed, not looking for work
  5. Retired, receiving retirement benefits
  6. Retired, not receiving benefits
Measured quarterly for 15 months.
Health status using Patient-Reported Outcomes Measurement InformationSystem (PROMIS) Scale 1.2
Time Frame: Measured quarterly for 15 months.

In general, how would you rate your physical/mental health?

  1. Excellent
  2. Very good
  3. Good
  4. Fair
  5. Poor
Measured quarterly for 15 months.
University of California Los Angeles (UCLA) Loneliness Short Version
Time Frame: Measured quarterly for 15 months.

3 item questionnaire: How often do you feel that you lack companionship?

How often do you feel left out? How often do you feel isolated from others?

  1. Hardly ever
  2. Some of the time
  3. Often
Measured quarterly for 15 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Southern California

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Miracle Messages

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Ben Henwood, PhD, University of Southern California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 6, 2022

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 1, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 15, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 26, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 1, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 7, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 15, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 12, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • UP-22-00242

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings